Portfolio Companies 2026 for Vida Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Vida Ventures accounts for 25 tracked companies with verified cap-table data, 25 of which disclose round sizes totalling $4.6B. The median disclosed raise is $165M, and the largest is ReCode Therapeutics at $570M, ahead of Cullinan Oncology ($499M) and Hexagon Bio ($323M).
The names that recur most often on these portfolio cap tables are Vida Ventures (25 companies), Polaris Partners (7 companies), OrbiMed (5 companies), The Column Group (4 companies), Nextech Invest (4 companies), Omega Funds (4 companies). By latest disclosed round, the market skews Series A (10), Series B (4), Series C (4), Seed (3).
Companies tracked: 25
Disclosed funding total: $4.6B across 25 companies
Median disclosed raise: $165M
Largest raise: ReCode Therapeutics — $570M
Stage mix: Series A 10 · Series B 4 · Series C 4 · Seed 3
